NAN
NANOSONICS FPO [NAN]
Healthcare · ASX Small Cap
$3.7000 +1.9%
Updated 26 Mar 2026 · Scores refresh every scan
Score Breakdown
Technical66
Catalyst50
Sentiment50
Fundamental87
Momentum41
Risk Gate40
Get alerts when NAN's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- MACD momentum is picking up steam
- Knocking on the door of resistance — if it punches through, things could get interesting
- Beating the Small Ords index — relative strength of 1.21, so it's outpacing the pack
- Volume-price trend suggests distribution — sellers may be sneaking out while price holds
- Volatility is contracting — like a spring being compressed, breakouts often follow
- Cash positive / operating cashflow positive
- Moderate P/S ratio (5.4x)
- Moderate revenue growth (+9%)
- Piotroski F-Score strong (8/9, low-confidence approx)
- EPS estimates revised upward (+3pts)
- Very high short interest (11.9%)
- CANSLIM A: Strong annual earnings CAGR (77%)
- CANSLIM I: Institutional ownership (62%)
- Sentiment is mixed — no strong consensus either way
- Days to cover very high (33.8)
- RBA hiking (-3pts)
Risk Signals
- Below the 200-day average — the long-term trend is still working against it
- Earnings declining (-1% QoQ)
- Not enough chatter to gauge sentiment — defaulting to neutral
- Long-term momentum is negative — down 23% over the past year
- The bigger volume days are the down days — volume-weighted momentum is negative (-0.64%/day)
- Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about NAN
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE Update - Notification of buy-back - NAN
NONE Update - Notification of buy-back - NAN
NONE Update - Notification of buy-back - NAN
Recent ASX Announcements
| 2026-03-22 | Update - Notification of buy-back - NAN |
| 2026-03-19 | Update - Notification of buy-back - NAN |
| 2026-03-18 | Update - Notification of buy-back - NAN |
| 2026-03-18 | Application for quotation of securities - NAN |
| 2026-03-17 | Update - Notification of buy-back - NAN |
Key Metrics
$1.1B
Market Cap
1.1M
Avg Volume
1.0x
Vol Ratio
$3.21 — $5.08
52-Week Range
11.9%
Short Interest
N/A
Cash Runway
10.1%
ROE
9.9%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | declining | EPS Growth: -1% |
| A | Annual Earnings | pass | CAGR: 77% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 84% |
| L | Leader vs Laggard | laggard | RS: -2 |
| I | Institutional Sponsorship | pass | Inst: 62% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #48 of 117 · Sector avg: 46
View all Healthcare signals →Track NAN and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.
No credit card required